WHO secures three licensing deals to boost Covid vaccine and assay product options
2023-08-29
疫苗引进/卖出紧急使用授权信使RNA
The World Health Organization has
secured
licensing agreements with Medigen Vaccine Biologics, the University of Chile and the Spanish National Research Council (CSIC) to increase the number of Covid-19 vaccine and assay product options for worldwide use. The licensing agreements fall under WHO’s Covid-19 Technology Access Pool (C-TAP).
Medigen is the first private manufacturer, as well as the first vaccine maker, to enter an agreement with C-TAP. The Taiwan-based biotech is licensing its Covid-19 vaccineCovid-19 vaccine, MVC COVID-19, and providing staff training to manufacturers. The protein subunit vaccine, which has emergency use authorization in Taiwan, has had three million doses administered in seven countries, according to a WHO press release.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
靶点
-热门报告
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。